⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Gut Microbiota–Bile Acid–FXR–FGF15 Muscle Axis
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-10 — PROfiles of FGF-19 Post-prandial Secretion in Older Adults With Frailty and Without Frailty: Human observational study description proposes profiling postprandial FGF-19 secretion in older adults with versus without frailty to investigate a candidate gut–muscle regulator and biomarker; no sample size, secretion differences, or muscle-outcome results are supplied, so neither a human association nor a causal muscle-maintenance effect is established [human-observational]. [human-observational] (novelty: 3)
- 2026-07-21 — β-Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota-bile acid-farnesoid X receptor (FXR/NR1H4) axis.: 2026 mouse AFB1 hepatotoxicity model: oral NMN remodeled gut microbiota, raised BSH activity, lowered conjugated bile acids, and activated intestinal FXR/FGF15 to suppress hepatic Cyp7a1 — causal support (antibiotic, FMT, intestine-specific FXR-KO) extending the same gut–BA–FXR–FGF15 architecture from muscle to liver injury, with an NAD+ precursor as the upstream trigger. [animal-model] (novelty: 3)
- 2026-06-06 — Association between bile acid metabolism and sarcopenia in older adults.: 2026 matched case-control serum metabolomics in older adults associates elevated 3β-HDCA and GLCA with primary sarcopenia (3β-HDCA also tracking slower 6-m gait speed) and reports a sleep-duration interaction whereby TLCA-linked sarcopenia risk is markedly higher in those sleeping >8 h — first human-cohort bile-acid species signal for the microbiota–bile-acid–muscle axis, observational only. [human-observational] (novelty: 3)
- 2026-09-22 — Effects of anti-aging diets and exercise on age-related musculoskeletal diseases via gut microbiota modulation.: 2026 review invokes diet- and exercise-induced remodeling of bile-acid-producing gut taxa as one candidate mechanism linking lifestyle interventions to sarcopenia via microbiota–muscle signaling, extending the axis from probiotic-BSH mechanistic studies to broader lifestyle levers — narrative synthesis only. [expert-opinion] (novelty: 3)
- 2026-06-08 — ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.: 2026 hepatic ACAT3 knockout study in male mice shows liver-side cholesterol esterification remodels the bile-acid pool and gut microbiota that this axis relies on for FXR–FGF15 signaling — adds a hepatic upstream input to the axis, no muscle endpoints measured. [animal-model] (novelty: 3)
- 2026-08-10 — HB05P on Muscle Health: cross-connection with gut-microbiota-healthspan: Akkermansia is a known bile-acid–pool modulator, so HB05P provides a human clinical probe of whether a gut-microbe intervention can move muscle-strength endpoints via candidate microbiota–bile-acid–muscle signaling. (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: cross-connection with sarcopenia-glam-metabolic-inflammatory-axis: Gut–liver–muscle bile-acid–FXR–FGF15 signaling is a concrete molecular instance of the GLAM crosstalk this framework asserts at the pathway level. (novelty: 3)
- 2026-07-28 — Bile salt hydrolase-active bifidobacterium animalis improves sarcopenia via the gut microbiota-bile acid-FXR-FGF15 axis and its functional fermented milk preparation.: Dexamethasone-induced sarcopenia mouse study: BSH-active Bifidobacterium animalis strains (delivered as fermented milk) remodeled the bile acid pool, activated intestinal FXR–FGF15 signaling and downstream muscle FGFR4/KLB, and attenuated muscle protein degradation. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
PROfiles of FGF-19 Post-prandial Secretion in Older Adults With Frailty and Without Frailty
10-nov-2026
novelty 3
per-area 3
strengthens
Fermented protein foods as modulators of the gut-muscle axis: mechanisms, evidence, and future directions.
25-sep-2026
novelty 2
per-area 2
mentions
Effects of anti-aging diets and exercise on age-related musculoskeletal diseases via gut microbiota modulation.
22-sep-2026
novelty 3
per-area 3
strengthens
Bile salt hydrolase-active bifidobacterium animalis improves sarcopenia via the gut microbiota-bile acid-FXR-FGF15 axis and its functional fermented milk preparation.
28-jul-2026
novelty 3
per-area 3
strengthens
β-Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota-bile acid-farnesoid X receptor (FXR/NR1H4) axis.
21-jul-2026
novelty 3
per-area 3
strengthens
Kimchi ProbioticWikim0187 Attenuates Age-Related Muscle Loss: Association with Gut Microbiota Remodeling in Mice.
17-jul-2026
novelty 3
per-area 2
strengthens
Aging-driven metabolic abnormalities remodel intercellular communication through the gut-liver-heart axis and may promote coronary artery disease: the key role of bile acid metabolism.
06-jul-2026
novelty 2
per-area 2
mentions
ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.
08-jun-2026
novelty 3
per-area 3
strengthens
Association between bile acid metabolism and sarcopenia in older adults.
06-jun-2026
novelty 3
per-area 3
strengthens